DENTSPLY SIRONA Management Performance Evaluation

XRAY -- USA Stock  

USD 37.07  0.79  2.18%

Analysis of DENTSPLY SIRONA manpower and management performance can provide insight into DENTSPLY SIRONA stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with DENTSPLY SIRONA future performance. See also Your Current Watchlist.

DENTSPLY SIRONA Management Effectiveness

The company has return on total asset (ROA) of 3.12 % which means that it generated profit of $3.12 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of (25.77) % meaning that it created substantial loss on money invested by shareholders.

DENTSPLY SIRONA Workforce Comparison

DENTSPLY SIRONA is rated below average in number of employees category among related companies. The total workforce of Medical Instruments & Supplies industry is at this time estimated at about 153,743. DENTSPLY SIRONA retains roughly 16,100 in number of employees claiming about 10% of all equities under Medical Instruments & Supplies industry.


The company has Profit Margin (PM) of (39.05) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 20.08 % which suggests for every 100 dollars of sales it generated a net operating income of 0.2.


DENTSPLY SIRONA Benchmark Summation

The output start index for this execution was zero with a total number of output elements of seventeen. DENTSPLY SIRONA Price Series Summation is a cross summation of DENTSPLY SIRONA price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.


Donald Casey CEO, Director
Mark Thierer Interim CEO
Jeffrey Slovin CEO, Director
Bret Wise Chairman, CEO and Chairman of Executive Committee
Maureen MacInnis Chief Human Resource Officer, Senior Vice President
Ulrich Michel CFO, Executive Vice President
Rainer Berthan Executive Vice President Manufacturing and Supply Chain
John Sweeney vice president IR Contact Officer
Deborah Rasin Vice President General Counsel, Secretary
Nicholas Alexos Executive Vice President Chief Administrative Officer
Albert Sterkenburg Senior Vice President
Keith Ebling Executive Vice President General Counsel, Secretary
Jonathan Friedman Senior Vice President General Counsel, Secretary
Christopher Clark Pres and CFO
James Mosch COO and Executive VP
Robert Size Sr. VP
Thomas Jetter Lead Director, Independent Director
Paula Cholmondeley Independent Director
Francis Lunger Independent Director
Harry Kraemer Director
Michael Coleman Independent Director
Betsy Holden Director
David Beecken Director
Leslie Varon Director
Eric Brandt Independent Director
Willie Deese Independent Director
John Miles Independent Director
William Hecht Lead Independent Director
Michael Alfano Independent Director
John Miclot Independent Director
Arthur Kowaloff Director
Derek Leckow VP, Investor Relations
Justin McCarthy General Counsel, Secretary



  Donald Casey  CEO
CEO, Director
  Mark Thierer  CEO
Interim CEO


DENTSPLY SIRONA Employment Tenure

DENTSPLY SIRONA employes about 16100 people. The company is managed by 33 executives with total tenure of roughly 156 years, averanging almost 4.0 years of service per executive having 487.0 employee per reported executive.

DENTSPLY SIRONAManpower Efficiency

Return on DENTSPLY SIRONA Manpower

Revenue Per Employee276 K
Revenue Per Executive124.2 M
Net Income Per Employee25.9 K
Net Loss Per Executive48.5 M
Working Capital Per Employee22.3 K
Working Capital Per Executive10.9 M

Per Employee

DENTSPLY SIRONA Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

See also Your Current Watchlist. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.